BioCentury
ARTICLE | Tools & Techniques

FNIH consortium launches NIMBLE to validate non-invasive NASH biomarkers

June 12, 2019 9:06 PM UTC

The Foundation for the National Institutes of Health Biomarkers Consortium launched the five-year NIMBLE program on Tuesday to assess, standardize and validate non-invasive imaging and blood-based biomarkers for non-alcoholic steatohepatitis that could eventually replace liver biopsy.

Non-invasive biomarkers could both facilitate patient recruitment to NASH trials by diagnosing and staging disease, and enable quicker assessment of therapeutic response. ...